Qureshi Z, Altaf F, Jamil A, Siddique R, et al. Meta-analysis of Targeted Therapies in EGFR-mutated Non-Small Cell Lung Cancer: Efficacy and Safety of Osimertinib, Erlotinib, and Gefitinib as First-line Treatment. Am J Clin Oncol 2024 Sep 11. doi: 10.1097/COC.0000000000001138.
PMID: 39257317